Cargando…
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection
Identification of neoepitopes that are effective in cancer therapy is a major challenge in creating cancer vaccines. Here, using an entirely unbiased approach, we queried all possible neoepitopes in a mouse cancer model and asked which of those are effective in mediating tumor rejection and, indepen...
Autores principales: | Brennick, Cory A., George, Mariam M., Moussa, Marmar M., Hagymasi, Adam T., Seesi, Sahar Al, Shcheglova, Tatiana V., Englander, Ryan P., Keller, Grant L.J., Balsbaugh, Jeremy L., Baker, Brian M., Schietinger, Andrea, Mandoiu, Ion I., Srivastava, Pramod K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843235/ https://www.ncbi.nlm.nih.gov/pubmed/33320837 http://dx.doi.org/10.1172/JCI142823 |
Ejemplares similares
-
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
por: Ebrahimi-Nik, Hakimeh, et al.
Publicado: (2021) -
Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection
por: Ebrahimi-Nik, Hakimeh, et al.
Publicado: (2019) -
The Bona Fide Nurse
Publicado: (1919) -
A bona fide MAP kinase
por: Oldach, Laurel
Publicado: (2022) -
What Are the bona fide GSK3 Substrates?
por: Sutherland, Calum
Publicado: (2011)